The gene therapy revolution is no longer on the horizon it’s here. 🚀 Billions are being invested, cutting-edge facilities are being built, and leading pharmaceutical companies are racing to scale up manufacturing.

But there’s a challenge threatening to slow this progress. And it’s not the science. It’s not the technology.

It’s leadership. 👔

There’s a critical shortage of experienced executive leaders who can transform gene therapy from laboratory promise into large-scale, compliant, and commercially viable operations.

At Wyman Bain, we believe the answer lies in a talent pool hiding in plain sight: senior manufacturing executives from the traditional pharmaceutical sector.

Why Traditional Pharma Leaders Are the Missing Link 🔑

Gene therapy manufacturing is complex, highly regulated, and evolving at pace. The sector needs leaders who can:

• 🏭 Build and scale GMP-compliant facilities
• 📜 Navigate regulatory minefields with confidence
• 💡 Drive operational excellence in sterile, high-stakes environments
• 🔗 Develop robust, future-proof supply chains

Sound familiar? These are the very skills honed by directors and VPs in established pharmaceutical manufacturing. Yet, many don’t realise just how directly transferable their expertise is to gene therapy.

The Problem: A Market in Transition ⚖️

Gene therapy companies are expanding rapidly, but the pool of leaders with direct experience in the field is vanishingly small.

Why?

• Traditional recruiters rely on databases and CVs—yet the best candidates aren’t actively looking and their résumés don’t say “gene therapy” (yet).
• Senior pharma executives can feel hesitant to leap into what seems like uncharted territory.

The result? A leadership bottleneck that risks holding the entire sector back. 🚧

Wyman Bain: The Bridge Between Worlds 🌍

This is where our research-led executive search makes the difference. Unlike database-driven firms, we go far beyond LinkedIn and job boards. Our consultants:

• 🔍 Conduct deep-dive market mapping across both traditional pharma and gene therapy
• 💬 Engage passive candidates with compelling, evidence-based career stories
• 📑 Deliver confidential, auditable shortlists that competitors can’t access
• 🤝 Advise both candidates and clients on how to make transitions successful

We don’t just fill roles.
We build bridges. 🌉

Case in Point: Manufacturing Leadership Transitions 🏗️

In recent months, demand has surged from gene therapy companies seeking Heads of Manufacturing, Quality, and Operations.

The ideal candidates? Often Directors and VPs from pharmaceutical giants who have:
✔️ Led sterile processing
✔️ Managed regulatory inspections
✔️ Overseen complex supply chains at scale

But these leaders aren’t on the open market. They need to be identified, educated, and engaged—a process that only a research-led, relationship-driven approach can deliver.

A Win for Everyone 🏆

• For gene therapy companies → Proven leaders who can hit the ground running, bringing operational rigour, compliance expertise, and scalability.
• For executives → The opportunity to play a pivotal role in one of the most exciting transformations in life sciences.
• For the sector → The catalyst needed to turn scientific breakthroughs into real-world cures. 🌍✨

Ready to Lead the Future? 🚀

If you’re a gene therapy company struggling to find the right manufacturing leadership—or a pharmaceutical executive curious about how your expertise could shape the next era of medicine Wyman Bain is here to help.

📩 Contact us for a confidential conversation. Together, we’ll build the leadership bridges that will define the future of gene therapy.

Wyman Bain: Exceptional people, not just the best available. Research-led executive search for manufacturing, pharma, and beyond. 🌟